GIM
MRNA icon

Grassi Investment Management’s Moderna MRNA Stock Holding History

Grassi Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,600
Closed -$276K – 132
2022
Q1 		$276K Buy
+1,600
New +$269K 0.03% 117
2021
Q4 		– Sell
-600
Closed -$231K – 149
2021
Q3 		$231K Buy
+600
New +$221K 0.03% 131

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grassi Investment Management's MRNA Position: Q2 2022 in Review

Grassi Investment Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 1,600 shares — an estimated $276K sold.

Grassi Investment Management first reported a position in MRNA in Q3 2021 and held it in 2 quarters. The position peaked at $276K in Q1 2022. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Grassi Investment Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Grassi Investment Management sold 1,600 Moderna shares in Q2 2022, an estimated $276K.
  • Grassi Investment Management first reported a position in Moderna in Q3 2021 and held it in 2 quarters.
  • Grassi Investment Management's Moderna position peaked at $276K in Q1 2022.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Grassi Investment Management's 13F filing for Q2 2022, filed 12 Jul 2022.